ENLISENSE TERMS AND CONDITIONS & PRIVACY POLICY
Updated as of March 5, 2026
Welcome to EnLiSense
We're thrilled you've decided to use our products and services. Before you dive in, it's important to establish some ground rules to ensure a smooth experience for everyone.
Don't worry, we've tried to keep this as straightforward as possible. Below, you'll find our Terms and Conditions, which outline your rights and responsibilities as a user of our services, as well as what you can expect from us.
By using our services, you agree to these terms. So, take a few minutes to read through them carefully. If you have any questions or concerns, feel free to reach out to us. Our contact details are also provided in this document.
Let's make this a great experience for everyone!
IMPORTANT NOTICES - READ CAREFULLY BEFORE USE
Table of Contents
Terms of Use Policy
CRITICAL PRODUCT CLASSIFICATION AND GUIDANCE FOR USE
BY USING ENLISENSE SERVICES, YOU ACKNOWLEDGE AND AGREE TO THE FOLLOWING CLASSIFICATIONS UNDER THE JANUARY 2026 FDA GENERAL WELLNESS POLICY.
1.1 Product Portfolio & Unified Wellness Classification
EnLiSense provides the following low-risk general wellness platforms (collectively, "Products" or "Devices"):
-
CORTI™ Family: A wearable stress and sleep monitor designed to track daily stress patterns, monitor sleep/wake cycles, and provide general lifestyle insights.
-
IBD AWARE®: A wearable wellness platform utilizing passive-sweat sensing to track physiological indicators related to digestive and gut health.
-
SWEAT AWARE®: Software for data analysis and visualization of wellness insights.
Regulatory Status: EnLiSense platforms are classified as low-risk general wellness products and are subject to FDA enforcement discretion. They are NOT FDA-cleared, approved, or authorized medical devices.
1.2 The General Wellness Framework
Based on the 2026 FDA criteria, our products serve two primary wellness functions:
-
General Health Function (Category 1): Claims relating to a general state of health, such as sleep management, relaxation, and physical fitness, without reference to specific diseases.
-
Living Well with Chronic Conditions (Category 2b): Claims relating to tracking choices and patterns that may help an individual live well with certain chronic conditions, such as inflammatory bowel disease (IBD). This classification is supported by peer-reviewed research linking habitual physical activity, stress, and sleep efficiency to the quality of life in IBD patients.
1.3 Intended Use & Permitted Applications
When using EnLiSense Devices, you acknowledge and agree that:
-
Permitted Wellness Uses: Tracking sleep routines, monitoring recovery for athletic wellness, observing personal biomarker trends, and supporting digestive wellness awareness.
-
Support for Chronic Conditions: Individuals may choose to monitor wellness trends alongside clinical care for chronic gastrointestinal conditions to gain insights into their digestive wellness.
-
Non-Invasive Safety: Our proprietary passive-sweat technology rests on the surface of the skin without penetration, does not require blood or tissue samples, and does not transfer energy into the body.
EnLiSense provides the following devices and services (collectively, "Products" or "Devices"):
- IBD AWARE® - Inflammatory biomarker monitoring system
- SWEAT AWARE® - Sweat analysis and wellness tracking software and associated applications, platforms, and data analytics services
- CORTI - Cortisol and stress biomarker monitoring system
FDA REGULATORY STATUS AND DISCLAIMERS
2.1 Explicit Non-Medical Statement
EnLiSense Products are NOT intended to:
-
Diagnose, treat, cure, or prevent any disease or medical condition.
-
Replace clinical tests such as colonoscopy, fecal calprotectin testing, or FDA-approved blood/urine tests.
-
Monitor or treat stress-related disorders (e.g., anxiety, depression, PTSD) or sleep disorders (e.g., apnea, insomnia).
-
Provide medical-grade accuracy or diagnostic thresholds.
2.2 No Clinical Action or Medical Advice
EnLiSense Devices provide data for general wellness - educational and awareness purposes only. The software will NOT prompt clinical action, such as alerts for medical decisions. Device data does not replace professional medical advice, diagnosis, or treatment.
2.3 Scientific Evidence for Wellness Claims
Disease-related wellness claims for IBD AWARE® are based on well-accepted relationships in peer-reviewed literature. These studies demonstrate:
-
Strong associations between accelerometrically determined physical activity and disease-specific quality of life.
-
A direct link between sleep efficiency and the activity status of IBD.
-
Significant interest from the patient community in utilizing wearables for stress and sleep monitoring to support their care.
2.4 International Regulatory Status
For users outside the United States:
- Products may not be approved by your local regulatory authority
- You are responsible for compliance with local medical device regulations
- Import, use, and distribution may be restricted in your jurisdiction
NOTE: When EnLiSense platforms are utilized within clinical or medical studies, such use is governed strictly by Institutional Review Board (IRB) oversight and investigational protocols; in these contexts, EnLiSense acts solely as a technology provider and assumes no clinical liability
USER OBLIGATIONS & SAFETY
3.1 Binding Agreement
By accessing, downloading, installing, registering for, or using any EnLiSense Services, you ("User," "you," or "your") acknowledge that you have read, understood, and agree to be legally bound by these Terms and Conditions ("Terms," "Agreement," or "Terms and Conditions") and our Privacy Policy, which is incorporated herein by reference.
3.2 Agreement to Terms Constitutes Acceptance
Your acceptance may be indicated by:
- Clicking "I Agree," "Accept," "Sign Up," or similar buttons
- Creating an account
- Downloading or installing our mobile applications
- Using any EnLiSense Device - Accessing any EnLiSense Service **IF YOU DO NOT AGREE TO THESE TERMS, DO NOT USE OUR SERVICES.**
3.3 Eligibility Requirements
Age Requirements:
- **General Wellness Users:** Must be at least 18 years of age or the age of majority in your jurisdiction, whichever is higher
- **Research Participants:** Age requirements specified in study-specific informed consent
- **Minors:** Use by individuals under 18 is prohibited except in approved IRB-supervised research with parental/guardian consent.
Legal Capacity:
- Must be legally capable of entering into binding contracts
- Must have authority to bind any entity on whose behalf you are acting
- Must not be legally prohibited from receiving or using the Services ####
Geographic Restrictions:
- Services may not be available in all jurisdictions
- Use may be restricted by local laws, regulations, or export controls
- You are responsible for compliance with applicable local laws
3.4 No Representation Regarding Accuracy
You represent and warrant that:
- All information provided during registration is accurate, current, and complete
- You will maintain and update such information to keep it accurate
- You are not impersonating any person or entity
- You have the legal right to use any payment methods provided
Providing false information constitutes material breach and grounds for immediate termination.**
3.5 Entity Users
If you are using Services on behalf of an organization, company, or other legal entity:
- You represent that you have authority to bind that entity to these Terms
- Both you and the entity are bound by these Terms
- References to "you" include both you and the entity ###
3.6 Changes to Terms
EnLiSense reserves the right to modify, amend, or update these Terms at any time, with or without notice, at our sole discretion. Changes are effective immediately upon posting to our website or Services.
*Your Responsibility:**
- Check Terms periodically for updates
- Continued use after changes constitutes acceptance
- If you disagree with changes, you must immediately cease use
**We are NOT obligated to provide individual notice of changes.**
3.7 Entire Agreement
These Terms, together with:
- Our Privacy Policy
- Any study-specific informed consent forms
- Product-specific terms and conditions
- Any additional legal notices or policies
Constitute the entire agreement between you and EnLiSense regarding your use of the Services, superseding all prior or contemporaneous communications, proposals, and agreements.
3.8 When to Seek Professional Care
You agree to immediately consult a healthcare professional if you experience concerning symptoms, as our devices are not designed to alert you to abnormal physiological conditions requiring medical attention.
3.9 Emergency Situations
CRITICAL: EnLiSense platforms are NOT designed for emergency use. In case of a medical emergency, call 911 (US) or local emergency services immediately. Do NOT rely on SWEAT AWARE® data for emergency decisions.
3.10 Ongoing Compliance Monitoring
EnLiSense conducts regular reviews of product classification status and monitors customer feedback to identify and prevent any unintended medical uses of our wellness platforms.
DEFINITIONS
For purposes of these Terms, the following definitions apply:
**"Company," "EnLiSense," "we," "us," or "our"** means EnLiSense and its affiliate companies, subsidiaries, affiliates, officers, directors, employees, agents, licensors, and suppliers.
**"User," "you," or "your"** means the individual or entity accessing or using the Services.
**"Services"** means all software, mobile applications, devices, products, websites, platforms, data analytics, and services provided by EnLiSense, collectively.
**"Devices" or "Products"** means IBD AWARE®, SWEAT AWARE®, CORTITM, and any other hardware devices provided by EnLiSense.
**"Personal Data" or "Personal Information"** means information that can identify you as an individual, as further defined in our Privacy Policy.
**"Health Data"** means biometric data, biomarker readings, wellness information, and health-related data collected through the Devices.
**"General Wellness Use"** means use of Devices for fitness, lifestyle, stress management, and general health awareness purposes, not for medical purposes.
**"Investigational Medical Use"** means use of Devices in clinical research, medical studies, or disease monitoring under healthcare professional supervision.
**"Informed Consent"** means a document signed by research participants that meets ethical and regulatory requirements for human subjects research. *
*"Healthcare Professional"** means a licensed physician, nurse practitioner, or other qualified medical professional authorized to provide medical care in their jurisdiction.
**"IRB"** means Institutional Review Board, an ethics committee that reviews and approves human subjects research.
GENERAL WELLNESS USE - CONSUMER APPLICATIONS
5.1 Scope of General Wellness Use
When using EnLiSense Devices for general wellness purposes, you acknowledge and agree that:
Permitted Uses:
- Personal health awareness and education
- Fitness tracking and performance optimization
- Stress management and lifestyle insights
- Sleep quality monitoring and improvement
- Nutritional and hydration awareness
- Personal biomarker trend observation
- Wellness goal setting and tracking
Prohibited Uses:
- Making medical diagnoses
- Determining treatment plans
- Monitoring active disease states
- Replacing prescribed medical devices
- Making medication decisions
- Managing chronic medical conditions
- Any use that requires FDA clearance
5.2 No Medical Purpose or Advice
You explicitly acknowledge that for general wellness use:
- Devices provide information for educational and awareness purposes ONLY
- Data and insights are NOT medical advice
- Results should NOT guide medical decisions
- Professional medical consultation is required for health concerns
- Devices do NOT detect, diagnose, or predict disease
5.3 Data Interpretation Limitations
Biomarker readings and health data provided through the Services:
- May vary due to numerous factors unrelated to health status
- Require context and professional interpretation for medical significance
- Are not validated for clinical decision-making
- Should not be used to self-diagnose or self-treat
- May not be accurate or reliable for all individuals
5.4 Lifestyle and Wellness Education
Information provided about:
- Biomarkers and their general functions
- Lifestyle factors affecting health
- General wellness principles
- Health optimization strategies
Is for educational purposes only and does not constitute personalized medical advice.
5.5 When to Seek Professional Care
You agree to immediately consult a healthcare professional if you:
- Experience concerning symptoms
- Have questions about your health status
- Observe unusual or unexpected readings
- Have pre-existing medical conditions
- Are pregnant or nursing
- Are taking medications
- Experience adverse reactions
5.6 Emergency Situations
CRITICAL: EnLiSense Services are NOT designed for emergency use. In case of medical emergency:
- Call 911 (US) or local emergency services immediately
- Do NOT rely on Device data for emergency decisions
- Seek immediate in-person medical care
MEDICAL DISCLAIMERS AND LIMITATIONS
6.1 No Physician-Patient Relationship
Use of EnLiSense Services does NOT create a physician-patient relationship or professional healthcare relationship between you and:
- EnLiSense or its affiliates
- Any healthcare professionals providing content
- Any employees or agents of EnLiSense
- Any third-party service providers
6.2 Not a Substitute for Professional Medical Care
YOU EXPRESSLY ACKNOWLEDGE:
- Services do NOT replace professional medical advice, diagnosis, or treatment
- Healthcare provider consultation is essential for medical concerns
- Device data should NOT be used to self-diagnose or self-treat
- Professional medical judgment supersedes Device information
- Delaying or avoiding medical care based on Device data may be harmful
6.3 Consultation Mandate
You MUST consult qualified healthcare providers regarding:
- Any medical symptoms or concerns
- Questions about health status or test results
- Treatment decisions or medication changes
- Management of chronic conditions
- Pregnancy or nursing-related health matters
- Interpretation of biomarker data for medical purposes
- Any health changes or unexpected readings
6.4 Accuracy and Reliability Limitations
EnLiSense makes NO warranties or representations regarding:
- Accuracy of Device readings or measurements
- Reliability of data under all conditions
- Completeness of information provided
- Suitability for any particular individual
- Freedom from errors or interruptions
- Correlation between readings and health status
Factors affecting accuracy may include:
- Individual biological variation
- Environmental conditions
- Device placement and usage
- Technical limitations
- User error or misuse
- Interference from other factors
6.5 Interpretation Limitations
Device readings and data:
- Require professional clinical context for interpretation
- May not reflect actual health status
- Can be affected by numerous non-disease factors
- Are not diagnostic indicators
- Should not be interpreted as medical results
6.6 Individual Variability
You acknowledge that:
- Biomarker levels vary significantly between individuals
- "Normal" ranges may not apply to all users
- Personal baselines differ
- Results may not be clinically significant
- Professional interpretation is essential
6.7 No Specific Outcome Guarantee
EnLiSense does NOT guarantee that use of Services will:
- Improve your health status
- Prevent disease or illness
- Detect health problems
- Provide accurate predictions
- Lead to any particular health outcome
6.8 Pre-Existing Conditions
If you have pre-existing medical conditions, you MUST:
- Consult your healthcare provider before use
- Follow medical advice over Device data
- Continue prescribed treatments and monitoring
- Report Device use to treating physicians
- Seek immediate care for symptom changes
6.9 Pregnancy and Nursing
Pregnant or nursing individuals:
- MUST consult healthcare providers before use
- Should not rely on Device data for pregnancy-related decisions
- Must seek immediate care for any concerning symptoms
- Acknowledge insufficient data on safety during pregnancy
7.10 Drug and Device Interactions
Device accuracy may be affected by:
- Prescription medications
- Over-the-counter drugs
- Supplements and vitamins
- Other wearable devices
- Medical implants
- Skin conditions or treatments
Consult your healthcare provider regarding potential interactions.
If our platform allows for user-generated content, you agree not to post content that:
-
Is defamatory, obscene, or discriminatory
-
Violates any intellectual property rights
-
Contains any form of advertising or solicitation
ASSUMPTION OF RISK AND USER ACKNOWLEDGMENTS
7.1 Voluntary Use and Risk Acceptance
BY USING ENLISENSE SERVICES, YOU VOLUNTARILY ASSUME ALL RISKS associated with such use, including but not limited to:
Technical Risks:
- Device malfunction or inaccuracy
- Software errors or bugs
- Data transmission failures
- Connectivity issues
- Technical limitations
Health-Related Risks:
- Reliance on inaccurate or misleading data
- Delayed medical care due to false reassurance
- Anxiety from misinterpreted results
- Skin irritation or allergic reactions
- Physical injury from device use
Data and Privacy Risks:
- Data breaches or unauthorized access
- Loss of confidentiality
- Misuse of personal information
- Third-party data sharing
Financial Risks:
- Costs of device and services
- Charges for unnecessary medical care
- Costs from device malfunction
7.2 Express Acknowledgments
You expressly acknowledge and agree that:
1. **No FDA Clearance:** Devices are not FDA-cleared or approved for any medical purpose
2. **Investigational Nature:** Medical applications are experimental and unproven
3. **Limited Evidence:** Claims are based on limited research and are not conclusive
4. **No Medical Supervision:** General wellness use occurs without medical oversight
5. **Personal Responsibility:** You are solely responsible for health decisions
6. **Data Limitations:** Device data may be inaccurate, incomplete, or misleading
7. **No Emergency Use:** Services are unsuitable for emergency situations
8. **Professional Consultation Required:** Medical advice from qualified professionals is essential
9. **Variation in Results:** Individual results and experiences will vary
10. **Continuous Development:** Products are subject to ongoing development and changes
7.3 Informed Decision-Making
You confirm that:
- You have read and understood all limitations and disclaimers
- You have had opportunity to ask questions
- You understand the investigational nature of medical use
- You accept uncertainty regarding accuracy and reliability
- You will not make medical decisions based solely on Device data
- You understand the importance of professional medical consultation
7.4 Feature and Capability Changes
You acknowledge that:
- Product features and capabilities may change as development continues
- New features may be added or removed
- Accuracy and functionality may improve or change over time
- We may discontinue certain features or services
- Updates may affect device performance
7.5 No Guarantees or Warranties
You understand that EnLiSense provides Services:
- "AS IS" and "AS AVAILABLE"
- Without warranties of any kind, express or implied
- Without guarantee of accuracy or reliability
- Without guarantee of fitness for any particular purpose
- Subject to all limitations stated in these Terms
7.6 Release of Liability
TO THE MAXIMUM EXTENT PERMITTED BY LAW, you release, waive, and forever discharge EnLiSense and its affiliates from any and all claims, liabilities, damages, or losses arising from your use of the Services, including:
- Health outcomes or adverse events
- Reliance on Device data
- Medical decisions made based on Services
- Technical failures or inaccuracies
- Any other use or misuse of Services
This release applies even if EnLiSense has been advised of the possibility of such damages.
LIMITATION OF LIABILITY
8.1 Maximum Liability Cap
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE TOTAL AGGREGATE LIABILITY OF EnLiSense AND ITS AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, AND SUPPLIERS (COLLECTIVELY, "ENLISENSE PARTIES") FOR ANY CLAIMS ARISING OUT OF OR RELATED TO YOUR USE OF THE SERVICES SHALL NOT EXCEED THE GREATER OF:
- (a) The total amount paid by you to EnLiSense in the twelve (12) months preceding the claim; OR
- (b) One hundred dollars ($100.00 USD)
8.2 Excluded Damages
ENLISENSE PARTIES SHALL NOT BE LIABLE FOR ANY:
Direct Damages:
- Personal injury or death
- Property damage
- Lost profits or revenue
- Cost of substitute goods or services
- Loss of data or information
- Loss of business opportunities
Indirect and Consequential Damages:
- Indirect, incidental, special, consequential, exemplary, or punitive damages
- Loss of use, goodwill, or reputation
- Emotional distress or mental anguish
- Medical expenses or health-related costs
- Costs of investigation or litigation
- Any other intangible losses
THIS LIMITATION APPLIES REGARDLESS OF:
- The legal theory (contract, tort, negligence, strict liability, warranty, or otherwise)
- Whether EnLiSense has been advised of the possibility of such damages
- Whether a limited remedy fails of its essential purpose
- Any failure of any exclusive remedy
8.3 No Liability for Third Parties
EnLiSense is NOT liable for:
- Actions or omissions of healthcare professionals
- Third-party service provider failures
- Actions of research institutions or IRBs
- Unauthorized access by third parties
- Content or services of linked websites
- Third-party data breaches
8.4 No Liability for Medical Outcomes
EnLiSense is explicitly NOT LIABLE for any health outcomes, medical decisions, or consequences resulting from:
- Use or misuse of Devices or Services
- Reliance on Device data or information
- Delays in seeking medical care
- Misinterpretation of results
- Device inaccuracy or malfunction
- Failure to receive medical advice
8.5 Force Majeure
EnLiSense shall not be liable for any failure or delay in performance due to circumstances beyond our reasonable control, including:
- Acts of God, natural disasters
- War, terrorism, civil unrest
- Government actions or regulations
- Pandemics or public health emergencies
- Labor strikes or disputes
- Failure of suppliers or vendors
- Telecommunications or internet failures
- Power outages or equipment failures
8.6 Basis of Bargain
You acknowledge that:
- These liability limitations are essential elements of the agreement
- EnLiSense would not provide Services without these limitations
- Fees charged reflect these allocations of risk
- You have accepted these limitations in exchange for access to Services
8.7 Jurisdictional Limitations
Some jurisdictions do not allow:
- Limitation of liability for personal injury or death
- Exclusion of implied warranties
- Limitation of incidental or consequential damages
In such jurisdictions, EnLiSense's liability is limited to the maximum extent permitted by law.
8.8 Separate Liability
Each provision of this limitation of liability section is separable and independent. If any provision is held invalid or unenforceable, the remaining provisions remain in full effect
INDEMNIFICATION
9.1 Your Indemnification Obligations
You agree to defend, indemnify, and hold harmless EnLiSense Parties from and against any and all third-party claims, actions, demands, liabilities, settlements, judgments, losses, damages, penalties, fines, costs, and expenses (including reasonable attorneys' fees, expert fees, court costs, and litigation expenses) arising out of or related to:
Use of Services:
- Your use or misuse of Devices or Services
- Your reliance on Device data or information
- Health decisions made based on Services
- Any adverse health outcomes
- Delay in seeking medical care
Breach of Terms:
- Violation of these Terms and Conditions
- Violation of any applicable laws or regulations
- Infringement of third-party rights
- Breach of representations and warranties
User Content and Conduct:
- Content you submit or transmit
- Your interactions with other users
- Unauthorized use of your account
- Violation of third-party intellectual property rights
False Representations:
- Misrepresentation of identity or credentials
- False information provided during registration
- Unauthorized use on behalf of another entity
- Fraudulent activity
9.2 Defense and Settlement
In the event of any claim requiring indemnification:
Notice: EnLiSense will provide prompt written notice of the claim.
Your Obligations:
- You agree to assume defense and control of the claim
- You will retain qualified legal counsel
- You will keep EnLiSense informed of proceedings
- You will not settle without EnLiSense's prior written consent
EnLiSense's Rights:
- We may participate in defense at our expense
- We may assume exclusive defense and control at your expense if you fail to defend adequately
- We have final approval over any settlement affecting our rights
9.3 Cooperation
You agree to:
- Cooperate fully with EnLiSense's defense efforts
- Provide requested information and documentation
- Make yourself available for depositions and testimony
- Not make any admissions prejudicial to EnLiSense
9.4 No Admission of Liability
Your indemnification obligations are independent of any liability limitations and do not constitute an admission of liability by EnLiSense.
USER RESPONSIBILITIES AND PROHIBITED CONDUCT
10.1 Lawful Use
You agree to use Services only for lawful purposes and in compliance with:
- All applicable local, state, federal, and international laws
- All regulations governing medical devices and health data
- Export control laws and sanctions
- Privacy and data protection laws
- Consumer protection laws
10.2 Accurate Information
You agree to:
- Provide accurate, current, and complete information during registration
- Maintain and update information to keep it accurate
- Not impersonate any person or entity
- Not provide false or misleading health information
- Not misrepresent your credentials or qualifications
10.3 Prohibited Uses
You shall NOT:
Unauthorized Medical Use:
- Use Devices for medical diagnosis without professional supervision
- Rely solely on Device data for medical decisions
- Use in clinical settings without proper authorization
- Make treatment decisions without healthcare professional consultation
- Use for emergency medical situations
Harmful Activities:
- Engage in fraudulent schemes or scams
- Harass, threaten, or harm other users
- Distribute malware, viruses, or harmful code
- Attempt unauthorized access to systems or accounts
- Interfere with or disrupt Services
- Overload or impair system functionality
Intellectual Property Violations:
- Reverse engineer, decompile, or disassemble Devices or software
- Copy, modify, or create derivative works without authorization
- Remove or alter proprietary notices or labels
- Use EnLiSense trademarks without permission
- Infringe third-party intellectual property rights
Data Misuse:
- Extract data through automated scraping or harvesting
- Use data for commercial purposes without authorization
- Share or sell access credentials
- Violate other users' privacy
- Export data in violation of regulations
Prohibited Content:
- Post defamatory, obscene, or discriminatory content
- Upload malicious or harmful materials
- Share false or misleading information
- Violate intellectual property rights
- Post unsolicited advertising or spam
10.4 Research Participant Responsibilities
If participating in clinical research, you must:
- Follow study protocol requirements
- Attend scheduled visits and assessments
- Report adverse events promptly
- Use Devices as instructed
- Not share Devices with others
- Maintain confidentiality of study information
10.5 Healthcare Professional Responsibilities
Healthcare professionals using Services must:
- Maintain appropriate professional standards
- Exercise independent clinical judgment
- Provide adequate patient oversight
- Obtain informed consent for medical use
- Comply with professional licensing requirements
- Report adverse events per regulatory requirements
10.6 Device Care and Maintenance
You agree to:
- Use Devices according to instructions
- Maintain Devices in good working condition
- Not modify or tamper with Devices
- Store Devices properly when not in use
- Replace components as recommended
- Not expose Devices to extreme conditions
10.7 Security Obligations
You must:
- Maintain confidentiality of login credentials
- Not share accounts with others
- Use strong, unique passwords
- Enable two-factor authentication if available
- Log out from shared devices
- Report security breaches immediately
10.8 Adverse Event and Safety Reporting
You must immediately report:
- Device malfunctions or defects
- Unexpected or serious adverse events
- Safety concerns
- Product quality issues
- Injuries related to device use
Report to: PR@enlisense.com or +1-703-349-6950
10.9 Consequences of Violations
Violation of these responsibilities may result in:
- Immediate termination of account and access
- Legal action and pursuit of damages
- Criminal prosecution where applicable
- Reporting to regulatory authorities
- Permanent ban from Services
ACCOUNT MANAGEMENT AND SECURITY
11.1 Account Creation
To access certain Services, you must create an account by providing:
- Valid email address
- Secure password
- Accurate personal information
- Payment information (for paid services)
- Health and demographic data (as requested)
11.2 Account Security
You are solely responsible for:
- Maintaining confidentiality of credentials
- All activities under your account
- Unauthorized access resulting from your negligence
- Security of devices used to access Services
Immediately notify EnLiSense of any unauthorized access or security breach.
11.3 Single User Accounts
Accounts are for individual use only:
- Do not share accounts with others
- Do not allow others to use your credentials
- Do not create accounts on behalf of others without authorization
- Devices are assigned to specific users and should not be shared
11.4 Account Information Accuracy
You must:
- Keep account information current and accurate
- Update information when it changes
- Verify email address and contact information
- Correct inaccurate health data promptly
12.5 Account Suspension
EnLiSense may suspend your account if:
- Suspicious activity is detected
- Payment fails or is disputed
- Investigation of Terms violation is ongoing
- Required information is not provided
- Security concerns exist
12.6 Data Retention After Termination
Upon account termination:
- Some data may be retained for legal or business purposes. EnLiSense retains the rights to all data retention.
- Anonymized data may be retained for research
- You may lose access to all account data
- We are not obligated to provide data copies
- Any particular issues/requests may be considered on a situational basis
CANCELLATION, REFUND, AND WARRANTY POLICY
12.1 Cancellation & Refund Policy
Built-to-Order Notice: EnLiSense sensors are specialized and functionalized immediately upon payment. They cannot be reused, reallocated, or scrapped once the process begins.
-
10-Day Window: Full refund requests are only accepted within 10 calendar days of payment and must include a documented "reason for good cause."
-
No Refunds: No refunds are issued after 10 days due to the custom nature of the hardware.
-
Default Policy: This stands as the default unless a separate written contract exists with EnLiSense.
12.2 Limited Hardware Warranty
EnLiSense provides a one (1) year limited warranty from the date of purchase on:
-
The EnLiSense Device (CORTI™ or IBD AWARE® platforms).
-
The included USB-C charging cable.
Note: A wall power adapter (charging block) is not included. Damage caused by faulty or non-certified third-party power adapters is not covered.
12.3 Warranty Exclusions
-
Consumable Sensors: Because sensors are functionalized to order and "used up" during operation, they are excluded from the 1-year warranty.
-
Reporting Window: Sensor issues must be reported as "Dead on Arrival" (DOA) within 30 days of receipt.
-
General Exclusions: Does not cover normal wear, accidental drops, liquid damage beyond ratings, or unauthorized repairs.
12.4 Replacement Process
If your hardware is defective:
-
Email: Contact pr@enlisense.com within the warranty period with proof of purchase.
-
Verify: Once the defect is verified, you will receive return instructions.
-
Remedy: EnLiSense will repair or replace the unit (new or refurbished) at our discretion.
-
Timeline: Replacements typically ship within 5–10 business days after we receive your defective unit.
12.5 No Refunds for Wellness Outcomes
EnLiSense products provide wellness insights and lifestyle tracking. We do not offer refunds or warranty credits for:
-
Dissatisfaction with biomarker data or "unexpected" readings.
-
Comparison against other consumer wearables or clinical tests.
-
Lack of perceived health improvements or any medical events.
INTELLECTUAL PROPERTY RIGHTS
13.1 Ownership of Company IP
All intellectual property related to EnLiSense Services, including but not limited to:
- Devices, sensors, and hardware
- Software, algorithms, and code
- Mobile applications and platforms
- Data analytics and processing methods
- Trademarks, logos, and branding
- Patents and trade secrets
- User manuals and documentation
- Website content and design
- Derivative data and insights
**(Collectively, "Company IP")** are and remain the exclusive property of EnLiSense.
13.2 Reserved Rights
EnLiSense retains ALL rights, title, and interest in Company IP, including:
- Copyright in software and content
- Patent rights in inventions and methods
- Trademark rights in brands and logos
- Trade secret protection
- Database rights
- All other intellectual property rights
13.3 Limited License Grant
Subject to your compliance with these Terms, EnLiSense grants you a limited, non-exclusive, non-transferable, revocable license to:
- Access and use Services for personal use (general wellness) or authorized research use
- Install and use mobile applications on your personal devices
- Use Devices according to instructions
- Access your personal account and data
This license does NOT permit:
- Commercial use or resale
- Modification or derivative works
- Reverse engineering or decompilation
- Sublicensing or transfer
- Removal of proprietary notices
- Any use not expressly authorized
13.4 Reverse Engineering Prohibition
You are **EXPRESSLY PROHIBITED** from:
- Reverse engineering, decompiling, or disassembling any Company IP
- Attempting to discover source code or algorithms
- Circumventing security or access controls
- Extracting or copying proprietary information
- Creating competing products or services
- Tampering with hardware or software
Violation constitutes material breach and may result in criminal prosecution.
13.5 Prohibited Uses of Company IP
You SHALL NOT without **WRITTEN AUTHORIZATION**:
- **Commercial Resale:** Resell, rent, or lease Devices or Services
- **Modification:** Alter, adapt, or create derivatives of Company IP
- **Unauthorized Copying:** Reproduce or distribute Company IP
- **Data Harvesting:** Use automated tools to extract data
- **Illegal Activity:** Use for fraudulent or criminal purposes
- **Unauthorized Access:** Attempt to access restricted systems
- **Network Disruption:** Interfere with service operation
- **Impersonation:** Impersonate EnLiSense or misuse branding
- **License Violation:** Use beyond scope of license grant
- **Export Violation:** Export to prohibited countries or entities
13.6 Data Ownership and Rights
Your Personal Data:
- You retain ownership of your personal information
- You grant EnLiSense license to use data as described in Privacy Policy
- License includes right to aggregate, anonymize, and analyze data
Aggregated and Anonymized Data:
- EnLiSense owns all aggregated and anonymized data
- May be used for research, product improvement, and commercial purposes
- No compensation owed for use of aggregated data
Research Data:
- Research study participants grant rights as specified in informed consent
- May include broader data use for research purposes
13.7 User Content
Any content you submit (feedback, suggestions, ideas):
- Becomes property of EnLiSense
- May be used without compensation or attribution
- Non-confidential and non-proprietary
- May be incorporated into products or services
13.8 Trademarks
EnLiSense trademarks and logos:
- Are protected marks owned by EnLiSense
- May not be used without express written permission
- Use in comparative advertising must comply with law
- Misuse may result in legal action
13.9 Copyright Infringement Claims
If you believe your copyright has been infringed, contact: legal@enlisense.com
Include:
- Identification of copyrighted work
- Location of infringing material
- Your contact information
- Statement of good faith belief
- Statement of accuracy and authority
- Signature
13.10 Enforcement and Remedies
EnLiSense will vigorously enforce intellectual property rights and may seek:
- Injunctive relief and cease orders
- Monetary damages
- Criminal prosecution where applicable
- Costs and attorneys' fees
SOFTWARE UPDATES AND TECHNICAL REQUIREMENTS
14.1 Automatic Updates
Services may include automatic software updates:
- Bug fixes and security patches
- Feature enhancements
- Performance improvements
- Compatibility updates
**By using Services, you consent to automatic updates.**
14.2 Update Requirements
You are responsible for:
- Installing updates promptly
- Maintaining compatible devices
- Ensuring adequate storage space
- Maintaining internet connectivity for updates
Failure to update may result in:
- Reduced functionality
- Security vulnerabilities
- Service incompatibility
- Lack of technical support
14.3 Technical Requirements
Compatible Devices:
- Smartphones: iOS 13.0+ or Android 12.0+
- Operating systems: As specified on website
- Bluetooth: 4.0 or higher
- Internet: Wi-Fi or cellular data connection
Storage and Performance:
- Adequate storage space for app and data
- Sufficient processing power
- Current operating system version
14.4 Beta Features
We may offer beta or experimental features:
- Marked as "beta," "preview," or "experimental"
- May be unstable or incomplete
- Subject to change or removal
- Use at your own risk
- No warranties or guarantees
14.5 Service Modifications
EnLiSense reserves the right to:
- Modify or discontinue features
- Change user interface or functionality
- Update algorithms or data processing
- Remove or add integrations
**Changes effective immediately upon implementation.**
14.6 Backward Compatibility
We do NOT guarantee:
- Support for older device or software versions
- Compatibility with discontinued products
- Access to deprecated features
- Data migration from legacy systems
DISPUTE RESOLUTION AND GOVERNING LAW
15.1 Mandatory Binding Arbitration
**IMPORTANT:** This section contains a binding arbitration clause and class action waiver that affects your legal rights. Read carefully.
**Agreement to Arbitrate:**
Any dispute, claim, or controversy arising out of or relating to these Terms or your use of EnLiSense Services shall be resolved through **MANDATORY BINDING ARBITRATION** rather than in court, except as specified in Section 19.2.
15.2 Scope of Arbitration
Subject to arbitration:
- Contract disputes
- Tort claims
- Statutory claims
- Disputes regarding these Terms
- Claims related to use of Services
- Intellectual property disputes
Not subject to arbitration:
- Small claims court matters (within jurisdictional limits)
- Claims for equitable relief (injunctions)
- Intellectual property enforcement actions
15.3 Arbitration Procedures
Forum and Rules:
- Conducted under American Arbitration Association (AAA) rules
- Commercial Arbitration Rules apply
- Consumer Arbitration Rules if applicable
- Location: Plano, Texas or mutually agreed location in Texas
Process:
1. Notice of dispute sent to other party
2. 30-day negotiation period
3. File arbitration demand with AAA
4. Arbitrator selection per AAA rules
5. Hearing scheduled and conducted
6. Arbitrator issues written decision
Costs:
- Filing fees per AAA rules
- Each party bears own attorney fees unless arbitrator awards otherwise
- Arbitrator fees split equally or as determined by arbitrator
15.4 Class Action Waiver
**YOU AGREE TO RESOLVE DISPUTES ON AN INDIVIDUAL BASIS ONLY.**
You waive the right to:
- Participate in class action lawsuits
- Bring representative actions
- Join consolidated proceedings
- Seek class-wide relief
**Each claim must be brought individually.**
15.5 Time Limitation for Claims
**Any claim must be filed within ONE (1) YEAR after the claim arises; otherwise, the claim is PERMANENTLY BARRED.**
Time begins to run:
- When you knew or should have known of the facts giving rise to the claim
- Not when damages are discovered
15.6 Governing Law
Law Applicable:
These Terms are governed by the laws of the **State of Texas, USA**, without regard to:
- Conflict of law principles
- United Nations Convention on Contracts for the International Sale of Goods
- Any other international treaties
Jurisdiction:
For matters not subject to arbitration:
- Exclusive jurisdiction: State and federal courts in Collin County, Texas
- You consent to personal jurisdiction in these courts
- You waive any objection to venue
15.7 Federal Arbitration Act
The Federal Arbitration Act (FAA) governs the interpretation and enforcement of this arbitration provision.
15.8 Opt-Out Right
You may opt out of arbitration by:
- Sending written notice within 30 days of accepting these Terms
- Send to: EnLiSense, 535 Talbert Drive, Suite 205, Plano, TX 75075
- Include name, address, and clear statement of opt-out intent
**Opt-out does not affect other Terms provisions.**
15.9 Severability of Arbitration Clause
If any part of this arbitration provision is found invalid or unenforceable:
- Class action waiver remains enforceable to maximum extent
- Remaining provisions continue to apply
- Invalid portion severed from Terms
15.10 Continuation After Termination
Arbitration provisions survive termination of account or Services.
TERMINATION RIGHTS
16.1 Your Right to Terminate
You may terminate your account and cease use of the EnLiSense Services at any time by:
-
Submitting a request through the account settings termination feature.
-
Emailing a formal notice to pr@enlisense.com.
16.2 Data Deletion & Privacy Compliance (CCPA/GDPR)
Upon a valid request for account termination and data deletion, EnLiSense adheres to the following protocol to ensure compliance with the California Consumer Privacy Act (CCPA) and the General Data Protection Regulation (GDPR):
-
PII Purging: We will permanently delete or "scrub" all Personally Identifiable Information (PII) from our active records, including your name, email address, username, and contact details.
-
Data De-Identification & Ownership: To maintain the integrity of our wellness analytics, all physiological and wellness data (biomarker trends, sleep patterns, etc.) will be de-identified and linked only to a non-identifiable UserID.
-
Ownership Rights: This de-identified data is owned exclusively by EnLiSense. It is used for internal research, platform improvement, and longitudinal wellness studies.
-
No External Sharing: EnLiSense will not share or sell this data to external third parties unless a specific, written contractual clause is in place with the user or a partner organization.
16.3 EnLiSense's Right to Terminate or Suspend
We reserve the right to terminate or suspend your access to the Services immediately, with or without notice, for reasons including:
-
Terms Violations: Any breach of these Terms or the General Wellness Use Policy.
-
Security Risks: Suspected unauthorized access, account compromise, or "excessive resource use" that threatens system stability.
-
Data Integrity: Providing false information during registration or failing to maintain accurate account data.
-
Inactivity: Accounts remaining inactive for a period of 12 consecutive months may be subject to automatic termination and de-identification.
16.4 Effect of Termination
Upon termination by either party:
-
Access: Your license to use the SWEAT AWARE® software and access your historical wellness dashboard expires immediately.
-
EU/UK Residents: In accordance with our GDPR Compliance Report, EU and UK residents may exercise their "Right to Erasure" (Article 17) or "Right to Portability" by contacting our EU Representative (EARP) as detailed in our Privacy Policy.
-
Survival: Provisions regarding Intellectual Property, Limitation of Liability, Indemnification, and Data Retention (of de-identified data) shall survive the termination of this agreement.
16.5 No Liability for Termination
EnLiSense shall not be liable to you or any third party for any damages, loss of data, or loss of "wellness insights" resulting from the termination of your account or the de-identification of your data records. Once PII is purged, accounts cannot be "reactivated" with previous personal identifiers; a new registration will be required.
GENERAL PROVISIONS
17.1 Entire Agreement
These Terms, together with the Privacy Policy and any study-specific informed consent, constitute the entire agreement between you and EnLiSense regarding the Services and supersede all prior:
- Agreements or understandings
- Oral or written communications
- Proposals or representations
- Other arrangements
17.2 Severability
If any provision of these Terms is found invalid, illegal, or unenforceable by a court of competent jurisdiction:
- That provision shall be severed
- Remaining provisions remain in full force
- Invalid provision interpreted to maximum valid extent
- Terms remain binding with minimal modification
17.3 Waiver
Failure or delay by EnLiSense to enforce any right or provision does NOT constitute waiver:
- No waiver of future enforcement
- No waiver of other provisions
- Waiver effective only if in writing
17.4 Assignment
Your Rights:
- You may NOT assign or transfer your rights or obligations under these Terms without our prior written consent
- Any attempted assignment is void
Our Rights:
- EnLiSense may freely assign these Terms in connection with:
- Merger or acquisition
- Sale of assets
- Corporate reorganization
- Any other business transfer
17.5 Notices
To You:
We may provide notice by:
- Email to registered address
- Posting on website or in Services
- In-app notifications
- Written notice to mailing address
Deemed received:
- Email: 24 hours after sending
- Website posting: Immediately
- Mail: 3 days after mailing
To Us:
Send notices to:
- Email: legal@enlisense.com
- Mail: EnLiSense, Legal Department, 535 Talbert Drive, Suite 205, Plano, TX 75093
17.6 Force Majeure
EnLiSense is not liable for failure or delay in performance due to events beyond reasonable control, including:
- Natural disasters (earthquakes, floods, hurricanes)
- Acts of God
- War, terrorism, civil unrest
- Government actions, laws, or regulations
- Pandemics or public health emergencies
- Labor strikes or disputes
- Supplier or vendor failures
- Telecommunications or internet outages
- Power failures
- Equipment malfunctions
During force majeure:
- Obligations suspended during event
- Reasonable efforts to resume services
- Users notified when practicable
17.7 Relationship of Parties
These Terms do NOT create:
- Partnership or joint venture
- Employment or agency relationship
- Franchise or distributor relationship
- Fiduciary relationship
**Each party is an independent contractor.**
17.8 No Third-Party Beneficiaries
These Terms are for the benefit of EnLiSense and you only. No third party has rights to enforce any provision.
Exception: EnLiSense affiliates, directors, officers, and employees are intended beneficiaries of limitation of liability and indemnification provisions.
17.9 Language
These Terms are drafted in English. Any translations are for convenience only. In case of conflict, English version controls.
17.10 Electronic Signatures and Records
You consent to:
- Electronic delivery of agreements and notices
- Electronic signatures having same effect as handwritten
- Electronic records satisfying writing requirements
17.11 Headings
Section headings are for convenience only and do not affect interpretation.
17.12 Interpretation
In these Terms:
- "Including" means "including but not limited to"
- Singular includes plural and vice versa
- "Or" is not exclusive
- "May" indicates permission, not obligation
17.13 Independent Legal Advice
EnLiSense recommends that you seek independent legal advice before accepting these Terms, particularly regarding:
- Arbitration and class action waiver
- Limitation of liability
- Medical disclaimers
- Data privacy practices
17.14 Forward-Looking Statements
Any forward-looking statements regarding:
- Future product development
- Planned features
- Research goals
- Business plans
Are subject to risks and uncertainties. Actual results may differ materially. We disclaim any obligation to update forward-looking statements.
Safe harbor: Statements protected under Private Securities Litigation Reform Act of 1995.
17.15 Export Controls
Services may be subject to U.S. export control laws and regulations. You agree to comply with all applicable export laws and NOT to:
- Export or re-export Services to prohibited countries or entities
- Use Services in violation of export restrictions
- Provide Services to sanctioned parties
17.16 Government Users
If you are a U.S. government entity, Services are "Commercial Items" as defined in FAR 2.101, provided with only those rights granted to the public under these Terms.
17.17 Feedback and Suggestions
Any feedback, suggestions, or ideas you provide:
- Are voluntary and non-confidential
- May be used without compensation
- Become property of EnLiSense
- No obligation to implement or respond
Privacy Policy
Your privacy is incredibly important to us, and we're committed to safeguarding your personal information.
We understand that legal documents can be a bit daunting, but we've done our best to make our Privacy Policy as clear and easy to understand as possible. This policy outlines how we collect, use, and protect your personal information when you interact with us, whether that's through our website, mobile app, or any of our products or services.
By using our services, you're agreeing to the terms outlined in this Privacy Policy. If you have any questions or concerns, don't hesitate to reach out to us. You'll find our contact details further down.
So, go ahead and take a few minutes to read through this policy. Your trust means everything to us, and we want to make sure you're fully informed about how we handle your data.
DATA PRIVACY, SECURITY, AND LICENSING
For complete information about data privacy practices, please review our full Privacy Policy incorporated herein by reference.
18.1 Privacy Commitment and Data Collection Limits
EnLiSense is built on a "Privacy by Design" architecture.
-
Minimal PII: We do not collect your legal name, physical address, or phone number.
-
User Control: We identify users solely through a unique Username and Email Address, which are managed and controlled by the user.
18.2 Data Ownership vs. Data Licensing
It is a fundamental condition of using EnLiSense Services that:
-
EnLiSense Ownership: EnLiSense retains full and exclusive ownership of all physiological data, biomarker trends, and de-identified datasets generated through our platforms (CORTI™ and IBD AWARE®).
-
No Transfer of Title: When EnLiSense shares de-identified data with research partners, clinical institutions, or service providers, it is provided under a restricted, non-exclusive, revocable license for a specific purpose only.
-
Strict Prohibitions: Any party granted access to EnLiSense data is legally prohibited from:
-
Claiming ownership or intellectual property rights over the data.
-
Attempting to re-identify any data to a specific individual.
-
Selling, sub-licensing, or distributing the data to third parties.
-
Using the data for any purpose outside of the strictly defined contractual agreement.
-
18.3 De-Identification Protocol (CCPA/GDPR Article 32)
To protect your identity while maintaining the value of the research, we employ a multi-layered de-identification process:
-
Pseudonymization: Your Email/Username is encrypted and stored in an isolated environment.
-
UserID Mapping: Wellness data is linked only to a randomized, non-identifiable UserID.
-
Research Integrity: This allows for longitudinal wellness studies while ensuring that even in the event of a licensed data transfer, your personal identity remains shielded.
18.4 Your Rights and the "Scrubbing" Process
In compliance with GDPR (Right to Erasure) and CCPA (Right to Deletion):
-
PII Deletion: Upon your request to terminate your account, we will permanently "scrub" (delete) your Email and Username from our active systems.
-
Residual Data: Because the underlying physiological data is de-identified and owned by EnLiSense, it will remain in our secure research database to support ongoing wellness analytics and sensor calibration.
18.5 International Data Safeguards
-
EU/UK Residents: EnLiSense acts as a Data Controller under GDPR Article 3(2). We maintain a dedicated EU Authorized Representative (EARP) to handle data subject requests and ensure all international transfers are protected by Standard Contractual Clauses (SCCs).
-
California Residents: We comply with all CCPA requirements. We do not sell personal information; therefore, no "Opt-Out" of sale is required.
18.6 Security Standards
-
Encryption: AES-256 for data at rest and TLS/SSL for data in transit.
-
Access Control: "Need-to-know" access protocols are enforced for all EnLiSense employees and contractors.
-
Breach Response: In accordance with our GDPR Compliance Report, we maintain a 72-hour notification protocol for relevant authorities in the event of a verified data breach.
THIRD-PARTY SERVICES AND INTEGRATIONS
19.1 Third-Party Integrations
EnLiSense Services may integrate with or link to third-party services, including:
- Payment processors
- Analytics platforms
- Cloud storage providers
- Health and fitness apps
- Research institutions
- Healthcare systems
- Social media platforms
19.2 No Control Over Third Parties
We do NOT control third-party services and are NOT responsible for:
- Content, accuracy, or availability
- Privacy practices or data security
- Terms and conditions
- Service disruptions or changes
- Data breaches or security incidents
- Any damages or losses from third-party use
19.3 Third-Party Terms Apply
Use of third-party services is subject to:
- Their own terms and conditions
- Their privacy policies
- Their data handling practices
You must review and agree to third-party terms independently.
19.4 Data Sharing with Third Parties
By using integrated services, you:
- Consent to data sharing as described in their policies
- Authorize necessary data transfers
- Assume responsibility for third-party data handling
19.5 No Endorsement
Inclusion of third-party services does NOT imply:
- Endorsement or recommendation by EnLiSense
- Verification of their safety or quality
- Responsibility for their actions
- Partnership or affiliation
19.6 Linking Policy
Who May Link:
Without prior approval:
- Government agencies
- Search engines
- News organizations
- Online directories
With approval (request via pr@enlisense.com):
- Consumer information sources
- Community sites
- Charitable organizations
- Professional firms
- Educational institutions
Link Requirements:
- Not deceptive or misleading
- No false implication of endorsement
- Contextually appropriate
- Does not harm our reputation
19.7 Third-Party Security
While we work with reputable providers:
- We cannot guarantee their security measures
- You assume risk of third-party breaches
- We are not liable for their security failures
19.8 Indemnification for Third-Party Use
You agree to indemnify EnLiSense for claims arising from:
- Your use of third-party services
- Your interactions with third parties
- Violation of third-party terms
- Third-party data breaches affecting you
CONTACT INFORMATION
20.1 General Inquiries
For questions, concerns, or comments regarding these Terms or EnLiSense Services:
Website: www.enlisense.com (contact form available in Feedback section)
Email:
- General: pr@enlisense.com
- Customer Support: pr@enlisense.com
- Sales: orders@enlisense.com
Phone: +1-703-349-6950
Mailing Address:
EnLiSense
535 Talbert Drive, Suite 205
Plano, TX 75093
USA
20.2 Legal and Compliance
Legal Department: legal@enlisense.com
Privacy Inquiries: PR@enlisense.com
Data Protection Officer: PR@enlisense.com
20.3 Safety and Adverse Events
Safety Department: PR@enlisense.com
20.4 Research and Clinical Inquiries
Research Department: PR@enlisense.com
Clinical Studies: PR@enlisense.com
20.5 Business Hours
Monday-Friday: 9:00 AM - 5:00 PM Central Time
(Excluding U.S. federal holidays)
**Emergency safety reports accepted 24/7.**
ACKNOWLEDGMENT OF UNDERSTANDING
**BY ACCESSING OR USING ENLISENSE SERVICES, YOU ACKNOWLEDGE THAT:**
1. You have read and understand these Terms and Conditions
2. You agree to be legally bound by these Terms
3. You understand the intended use classifications (general wellness vs. investigational medical)
4. You acknowledge that Devices are NOT FDA-cleared or approved
5. You understand medical applications are investigational and require professional supervision
6. You will seek healthcare professional advice for medical concerns
7. You assume all risks associated with use of Services
8. You agree to binding arbitration and class action waiver
9. You consent to data practices described in Privacy Policy
10. You will comply with all applicable laws and these Terms
**IF YOU DO NOT AGREE TO THESE TERMS, DO NOT USE ENLISENSE SERVICES.**
---
REVISION HISTORY
Version 3.0 - March 5, 2026
- Restructured for enhanced legal protection and regulatory compliance
- Prominent placement of intended use classifications
- Strengthened FDA disclaimers
- Enhanced medical disclaimers and limitations
- Clarified dual-use framework (wellness vs. investigational medical)
- Expanded informed consent requirements for research use
- Strengthened limitation of liability provisions
- Enhanced user acknowledgment and assumption of risk sections
- Updated privacy and data security provisions
- Improved clarity and organization throughout
Version 1.0 - September 1, 2023
Version 2.0 - November 4, 2025
- Original Terms and Conditions
---
Last Updated: November 4, 2025
Effective Date: November 4, 2025
---
© 2023-2026 EnLiSense. All Rights Reserved.
Trademarks: IBD AWARE®, SWEAT AWARE®, and CORTITM are registered trademarks of EnLiSense.